Safety of trastuzumab after trastuzumab emtansine-induced nodular regenerative hyperplasia: A case report

Introduction Trastuzumab emtansine is an antibody-drug conjugate targeting the human epidermal growth factor receptor 2 use in recurrent metastatic breast cancer. Cases of trastuzumab emtansine-induced nodular regenerative hyperplasia are often reported as overt noncirrhotic portal hypertension with...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of oncology pharmacy practice 2020-10, Vol.26 (7), p.1780-1784
Hauptverfasser:	Hassan, Chadi, Correal, Florence, Vézina, Gabriel, Yelle, Louise, Adam, Jean-Philippe
Format:	Artikel
Sprache:	eng
Schlagworte:	Ado-Trastuzumab Emtansine - administration & dosage Ado-Trastuzumab Emtansine - adverse effects Antineoplastic Agents - adverse effects Ascites Breast cancer Breast Neoplasms - drug therapy Case reports Cirrhosis Epidermal growth factor ErbB-2 protein Esophageal and Gastric Varices - chemically induced Female Gastrointestinal Hemorrhage - chemically induced Humans Hyperplasia Hyperplasia - chemically induced Hypertension Immunotherapy Liver Liver cirrhosis Metastases Metastasis Middle Aged Monoclonal antibodies Neoplasm Recurrence, Local Platelets Receptor, ErbB-2 - metabolism Targeted cancer therapy Trastuzumab
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!